Replies to post #402028 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

I am not sure I fully understand your question. Are you asking why did it take so long to:

(1) Perform the data-lock on the DCVax-L trial? or,

(2) Announce the DCVax-L topline data results and have the top tier, peer-reviewed journal article published?

[flipper44]

I think it’s due to the originating status of this trial. To run trials in other indications for DCVax-l, the data, design, confidence and a host of other factors from this trial will be utilized to design shorter trials with logical endpoints, imo. You really can’t do that, unless the evidence is water tight enough that one can scientifically correlate certain endpoints to true efficacy. They took time now to save time later.